- Home
- INSM vs JD Comparison
INSM vs JD Comparison
Compare INSM & JD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSM
- JD
- Stock Information
- Founded
- INSM 1988
- JD 2006
- Country
- INSM United States
- JD China
- Employees
- INSM N/A
- JD N/A
- Industry
- INSM Biotechnology: Pharmaceutical Preparations
- JD Other Specialty Stores
- Sector
- INSM Health Care
- JD Consumer Discretionary
- Exchange
- INSM Nasdaq
- JD Nasdaq
- Market Cap
- INSM 41.2B
- JD 48.9B
- IPO Year
- INSM 2000
- JD 2014
- Fundamental
- Price
- INSM $206.24
- JD $29.53
- Analyst Decision
- INSM Strong Buy
- JD Buy
- Analyst Count
- INSM 19
- JD 11
- Target Price
- INSM $173.35
- JD $42.00
- AVG Volume (30 Days)
- INSM 3.0M
- JD 13.3M
- Earning Date
- INSM 10-30-2025
- JD 11-13-2025
- Dividend Yield
- INSM N/A
- JD 3.40%
- EPS Growth
- INSM N/A
- JD N/A
- EPS
- INSM N/A
- JD 2.99
- Revenue
- INSM $447,022,000.00
- JD $183,136,729,092.00
- Revenue This Year
- INSM $40.09
- JD $15.57
- Revenue Next Year
- INSM $129.64
- JD $5.67
- P/E Ratio
- INSM N/A
- JD $9.85
- Revenue Growth
- INSM 30.34
- JD 16.63
- 52 Week Low
- INSM $60.40
- JD $28.21
- 52 Week High
- INSM $209.77
- JD $46.45
- Technical
- Relative Strength Index (RSI)
- INSM 70.57
- JD 38.31
- Support Level
- INSM $194.65
- JD $28.21
- Resistance Level
- INSM $209.77
- JD $29.50
- Average True Range (ATR)
- INSM 6.85
- JD 0.80
- MACD
- INSM 0.15
- JD -0.08
- Stochastic Oscillator
- INSM 86.77
- JD 35.08
About INSM Insmed Incorporated
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.
About JD JD.com Inc.
JD.com is the third-largest Chinese e-commerce platform by GMV in 2024. it offers a wide selection of authentic products with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.